New products available: Beta-amyloid 1-42 antibodies

Alzheimer’s disease is a progressive neurodegenerative disease and the most common cause of dementia. We provide three in vitro produced monoclonal antibodies that are specific to human beta-amyloid 1-42. Read more here.